Last updated: 11/07/2018 08:28:04
SUrvey of Guideline Adherence for treatment of systolic heart failure in Real WorldSUGAR
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: SUrvey of Guideline Adherence for treatment of systolic heart failure in Real WorldMulticenter, retrospective observation study in Korea
Trial description: The purpose of this study is to survey the guideline compliance of the cardiologists in the treatment of systolic heart failure in Korea
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Mean of modified Guideline Adherence Indicator(mGAI-3)
Timeframe: 1year
Secondary outcomes:
Percentage of participants with each class drug prescribed
Timeframe: 1year
Percentage of participants with daily target dose reached
Timeframe: 1year
Percentage of all cause mortality
Timeframe: 1year
Percentage of All cause hospitalization
Timeframe: 1year
Mean of mortality or rehospitalization rate according to mGAI-3
Timeframe: 1year
Interventions:
Other: guideline adherence
Enrollment:
1
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Hong B, Shin D, Bae J, Yang D, Shim W, Kim H, Kim S, Choi D, Choi J, Chun W, Go C, Kang H, Baek S, Cho J, Hong S, Kang S, Shin J, Oh S, Yoo B, Pyun W, Kwan J, Hong Y, Jeong J, Oh J. Survey of guideline adherence for treatment of systolic heart failure in real world. PLoS ONE. 2013;9(1)
Medical condition
Heart failure, Congestive
Product
Not applicable
Collaborators
Not applicable
Study date(s)
March 2011 to October 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
20+ years
Accepts healthy volunteers
No
- Subjects admitted to hospital with systolic heart failure(LVEF under 45%) in 2009
- Subjects, age 20 or/and above
- Subject who expired during hospitalization
Inclusion and exclusion criteria
Inclusion criteria:
- Subjects admitted to hospital with systolic heart failure(LVEF under 45%) in 2009
- Subjects, age 20 or/and above
- Subjects admitted to hospital (emergency area, to internal medicine or to cardiology wards, CCU or intensive care) with dyspnea and verification of heart failure based on following criteria;
- Symptoms typical of heart failure : breathlessness at rest or on exercise, fatigue, tiredness, ankle swelling and Signs typical of heart failure : tachycardia, tachypnoea, pulmonary rales, pleural effusion, raised jugular venous pressure, peripheral oedema, hepatomegaly
- Objective evidence of a structural or functional abnormality of the heart at rest : cardiomegaly, third heard sound, cardiac murmurs, abnormality on the echocardiogram, raised natriuretic peptide concentration
Exclusion criteria:
- Subject who expired during hospitalization
Trial location(s)
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2011-31-10
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website